Delaware Clinical and Translational Research ACCEL Program-Tracking and Eval Core

摘要跟踪与评估(T&E) 特拉华州临床和转化部的跟踪和评估(T&E)关键组件活动(KCA) (去CTR)Accel计划将定义并促进这一复杂研究基础设施的持续成功 程序。T&E活动的主要主旨将超越最初对研究生产率的核算，这 在该计划的前四年一直很高，并在更新期间专注于新的倡议， KCA之间的整合质量，以及Accel计划的整体影响。教育和经济活动的具体目标是：1) 开发定义的指标，用于指导每个KCA的数据收集、分析和报告，以帮助Accel Lead- 具有领导计划改进、扩大和有效利用资源的能力；2)监测和报告进展情况 通过标准化报告和实时报告实现KCA的具体目标和总体计划成果 基于Web的界面；3)通过监控过程和产品，并通过实施 流程改进，以减少错误和提高效率；以及4)制定和分享跟踪方面的最佳做法 跨机构和与其他IDEA方案密切合作的评估，包括国家CTR 评估者小组和南卡罗来纳州临床和翻译研究所(SCTR)。要实现这些目标 AIMS，除了整体ACEL的特定目标外，我们还将利用代表每个机构和每个机构的联系人 KCA。我们将收集KCA特定的指标，向Accel成员、领导力、咨询委员会提供反馈 成员和NIH工作人员。这些评估数据将定义我们在多大程度上增加沟通、扩展 跨学科和跨机构协作，优化决策，促进资源共享。 我们还将讨论Accel在需求和机会领域增加容量的程度，改善 与社区建立联系，并将合作和基础设施扩展到特拉华州立大学。无关紧要- 在这一更新期间，我们将加强南方医科大学T&E合作者的作用 卡罗莱纳州(MUSC)。他们的专业知识将使我们能够更有效地将成果为基础的问责、利用- 将集中评价、发展性评价理论和精益六西格玛方法引入技术与工程，并将 促进采用基于CTSA的倡议。确保T&E提供的反馈质量始终如一 高度和相关的用户和领导层的需求，我们将呼吁MUSC联络的专业知识，以提供 客观保证电教活动的质量。我们预计，基于Accel在第一次融资期间的经验 在此期间，我们高度协作，继续专注于加强跨机构和跨学科的努力- 演讲文化将促进进一步有效的项目建设和资源的使用，以支持临床和翻译。 有利于特拉华州社区的全国性研究。

Abstract—Tracking & Evaluation (T&E) The Tracking and Evaluation (T&E) Key Component Activity (KCA) of the Delaware Clinical and Translational (DE-CTR) ACCEL Program will define and facilitate the ongoing success of this complex research infrastructure program. The major thrust of T&E activities will move beyond the initial accounting of research productivity, which has been high during the first four years of the program, and focus during the renewal period on new initiatives, the quality of integration among KCAs, and the overall impact of the ACCEL program. The Specific Aims of T&E are to: 1) Developmentally define metrics that guide data collection, analysis, and reporting for each KCA to aid ACCEL Lead- ership in directing program improvement, expansion and efficient use of resources; 2) Monitor and report progress towards KCA Specific Aims and overall program accomplishments delivered via standardized reports and real-time web-based interfaces; 3) Assure quality of T&E activities by monitoring processes and products, and by implementing process improvements to reduce errors and improve efficiency; and 4) Develop and share best practices in tracking and evaluation across institutions and in close partnership with other IDeA programs, including the National CTR Evaluators Group, and the South Carolina Clinical and Translational Research Institute (SCTR). To achieve these aims, in addition to the Overall ACCEL Specific Aims, we will utilize Liaisons representing each institution and each KCA. We will collect KCA-specific metrics that provide feedback to ACCEL members, leadership, advisory council members, and NIH staff. These evaluation data will define the degree to which we increase communication, expand interdisciplinary and inter-institutional collaborations, optimize decision-making, and facilitate resource-sharing. We will also address the degree to which ACCEL increases capacity in areas of need and opportunity, improves con- nections with the community, and expands collaborations and infrastructure to Delaware State University. Impor- tantly, during this renewal period we will enhance the role of T&E collaborators at the Medical University of South Carolina (MUSC). Their expertise will allow us to more effectively incorporate Results Based Accountability, Utili- zation Focused Evaluation, Developmental Evaluation Theory, and Lean Six Sigma methodology into T&E, and will facilitate adoption of CTSA-based initiatives. To ensure that the quality of feedback provided by T&E is consistently high and relevant to the needs of users and leadership, we will call upon the expertise of MUSC Liaisons to provide objective quality assurance of T&E activities. We anticipate, based the experience of ACCEL during this first funding period, that a continued focus on strengthening cross-institutional and cross-disciplinary efforts in our highly collab- orative culture will facilitate further effective program building and use of resources in support of clinical and transla- tional research that benefit the Delaware community.